Fortrea (Nasdaq: FTRE) has signed a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE